Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress

Posted: October 16, 2021 at 2:47 am

CAMBRIDGE, Mass., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced an oral presentation at the European Society of Gene and Cell Therapy (ESGCT) Annual Virtual Congress taking place October 19-22. The presentation will highlight preclinical advances from the company’s retina therapeutic area.

See the rest here:
Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress

Related Posts